SLTM anticorps
-
- Antigène Voir toutes SLTM Anticorps
- SLTM (SAFB-Like, Transcription Modulator (SLTM))
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp SLTM est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Attributs du produit
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogène
- Synthetic peptide of human SLTM
- Isotype
- IgG
- Top Product
- Discover our top product SLTM Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- SLTM (SAFB-Like, Transcription Modulator (SLTM))
- Autre désignation
- SLTM (SLTM Produits)
- Sujet
- SLTM (SAFB-like, transcription modulator), also known as MET (modulator of estrogen-induced transcription), is a 1,034 amino acid protein that localizes to punctate structures within the nucleus and contains one SAP domain and one RNA recognition motif. When expressed at high levels, SLTM functions to inhibit transcription and may, ultimately, lead to apoptosis. Multiple isoforms of SLTM exist due to alternative splicing events. The gene encoding SLTM maps to human chromosome 15, which houses over 700 genes and comprises nearly 3 % of the human genome.
- Poids moléculaire
- 117 kDa
- NCBI Accession
- NP_079031
- UniProt
- Q9NWH9
-